NCT06360133

Study of 5% VVN001 Ophthalmic Solution in Dry Eye Disease

A Phase 3, Randomized, Double-Masked, Vehicle-controlled, Multi-center Study Evaluating the Safety and Efficacy of 5% VVN001 in Chinese Subjects With Dry Eye Disease

• Status: Recruiting
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 700 (estimated)
• Sponsor: VivaVision Biotech, Inc · Industry
• Sex: All
• Age: 30 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

This is a Phase 3, randomized, double-Masked, vehicle-controlled, multi-center study designed to evaluate the safety and efficacy of 5% VVN001 Ophthalmic Solution versus vehicle in Chinese subjects with dry eye disease.

Conditions

• Dry Eye

Interventions

Type	Name	Description
DRUG	VVN001 Ophthalmic Solution, 5%	VVN001 Ophthalmic Solution, 5%
DRUG	VVN001 Ophthalmic Solution, Vehicle	VVN001 Ophthalmic Solution, Vehicle

Timeline

• Start date: 2024-04-01
• Primary completion: 2026-03-31
• Completion: 2026-03-31
• First posted: 2024-04-11
• Last updated: 2024-11-20

Locations

1 site across 1 country: China